Technical Analysis for ASMB - Assembly Biosciences, Inc.

Grade Last Price % Change Price Change
grade D 13.0 7.71% 0.93
ASMB closed up 7.71 percent on Friday, November 15, 2019, on approximately normal volume. The stock rose above its 50 day moving average, improving its intermediate-term outlook by crossing above that important trendline. Note that the stock is in oversold territory based on its Slow Stochastic indicator (14, 3, 3) -- sideways movement or a bounce should not be unexpected.

Earnings due: Dec 1

*** please verify all earnings dates ***
5 Watchers
View Intraday Alerts Watchlist Portfolio

Trend Table & Recent Signals
ADX Long-Term Intermediate-Term Short-Term
Strong Down Up Down
See historical ASMB trend table...

Date Alert Name Type % Chg
Crossed Above 50 DMA Bullish 0.00%
1,2,3 Pullback Bullish Bullish Swing Setup 0.00%
Non-ADX 1,2,3,4 Bullish Bullish Swing Setup 0.00%
Inside Day Range Contraction 0.00%
Wide Bands Range Expansion 0.00%
Lower Bollinger Band Touch Weakness 0.00%
Oversold Stochastic Weakness 0.00%
Fell Below 50 DMA Bearish 7.71%
1,2,3 Pullback Bullish Bullish Swing Setup 7.71%
Wide Bands Range Expansion 7.71%

Older signals for ASMB ...

Free Daily (Stock) Chart Reading

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Analyze My Stocks!
Configure default chart indicators
ASMB Chart by TradingView
Basic chart:
Profile
Assembly Biosciences, Inc. provides development and commercialization of gastrointestinal products in the United States. The company is developing two late-stage development product candidates, including VEN 307, a diltiazem cream for the relief of pain associated with anal fissures; and VEN 308, a phenylephrine gel for the treatment of fecal incontinence associated with ileal pouch anal anastomosis. It is also involved in the development of VEN 310 as a colonic delivery mechanism, which is a PH sensitive system to deliver bacteria, complex proteins, viral antigens, small molecules, and other treatments. The company was formerly known as Ventrus Biosciences Inc. and changed its name to Assembly Biosciences, Inc. in July, 2014. Assembly Biosciences, Inc. was founded in 2005 and is based in New York, New York.
Medicine Medical Specialties Gastroenterology Digestive System Digestive System Surgery Large Intestine Fecal Incontinence Gastrointestinal Products
Is ASMB a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 3 bullish, 2 bearish and 0 neutral indicators. You may wish to incorporate that into your trading strategies.
Recent News
Date Title
Nov 11 Assembly Bio up 7% on positive HBV core inhibitor data
Nov 11 WBA, SPWR among top premarket gainers
Nov 11 Data for Assembly Biosciences’ First and Second Generation HBV Core Inhibitors in Development for the Treatment of Chronic Hepatitis B Highlighted in Late-Breaker Poster Session at AASLD 2019
Nov 10 The Week Ahead In Biotech: Adcom Test For Amarin's Fish Oil Pill, Agile Awaits FDA Verdict
Nov 8 Why It Could Soon Be Time To Take Profits In This Highflying Biotech Stock
Nov 7 Assembly Biosciences EPS misses by $0.03, beats on revenue
Nov 7 Assembly Biosciences Reports Third Quarter 2019 Financial Results and Recent Highlights
Nov 7 Analysts Estimate Assembly Biosciences (ASMB) to Report a Decline in Earnings: What to Look Out for
Nov 7 Assembly Biosciences Appoints Luisa Stamm, MD, PhD, as Chief Medical Officer
Nov 6 Hedge Funds Are Selling Assembly Biosciences Inc (ASMB)
See more ASMB news...
Indicators
Indicator Value
52 Week High 27.6
52 Week Low 8.1301
Average Volume 698,077
200-Day Moving Average 15.2916
50-Day Moving Average 12.8194
20-Day Moving Average 15.1733
10-Day Moving Average 15.1075
Average True Range 1.651
ADX 37.32
+DI 24.1139
-DI 20.4512
Chandelier Exit (Long, 3 ATRs ) 14.047
Chandelier Exit (Short, 3 ATRs ) 16.583
Upper Bollinger Band 17.9122
Lower Bollinger Band 12.4344
Percent B (%b) 0.1
BandWidth 36.101573
MACD Line 0.3047
MACD Signal Line 0.8482
MACD Histogram -0.5436
Fundamentals Value
Market Cap 225.73 Million
Num Shares 17.4 Million
EPS -2.93
Price-to-Earnings (P/E) Ratio -4.44
Price-to-Sales 176.68
Price-to-Book 9.51
PEG Ratio 0.00
Dividend 0.00
Dividend Yield 0.00%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 15.03
Resistance 3 (R3) 14.92 14.15 14.69
Resistance 2 (R2) 14.15 13.63 14.20 14.57
Resistance 1 (R1) 13.57 13.31 13.86 13.68 14.46
Pivot Point 12.80 12.80 12.94 12.85 12.80
Support 1 (S1) 12.22 12.28 12.51 12.33 11.54
Support 2 (S2) 11.45 11.96 11.50 11.43
Support 3 (S3) 10.87 11.45 11.31
Support 4 (S4) 10.98